TY  - GEN 
AU  - Quiñonero Muñoz, Francisco José
AU  - Parra Torrejón, Belén
AU  - Ramírez Rodríguez, Gloria Belén
AU  - Garcés Robles, Víctor Jesús
AU  - Delgado López, José Manuel
AU  - Jiménez Luna, Cristina
AU  - Perazzoli, Gloria
AU  - Melguizo Alonso, Consolación
AU  - Prados Salazar, José Carlos
AU  - Ortiz Quesada, Raúl
PY  - 2023
UR  - https://hdl.handle.net/10481/85261
AB  - Introduction: Pancreatic cancer (PC) shows a very poor response to current treatments. Development of drug resistance is one of the
causes of the therapy failure, being PARP1 (poly ADP-ribose polymerase 1) a relevant protein in the resistance...
LA  - eng
PB  - Dove Medical Press LTD
KW  - Nanomedicine
KW  - Calcium phosphate nanocarriers
KW  - Olaparib
KW  - Ascorbic acid
KW  - Synergistic effect
TI  - Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
DO  - 10.2147/IJN.S415631
ER  -